Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20 Stomach Neoplasms 2 Inflammatory Breast Neoplasms 2 Rectal Neoplasms 1 Neoplastic Cells, Circulating 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Invasive Breast Cancer 1 HER2 Positive Breast Cancer 1 Elderly Metastatic Breast Cancer Population 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiotoxicity 1 Breast Neoplasms, Male 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Cancer 1

Interventions

Trastuzumab 1 IFL protocol 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Advanced Cancer × Trastuzumab × Clear all

NCT05605509 2026-02-06

RP-6306 in Patients With Advanced Cancer

Canadian Cancer Trials Group

Phase 2 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡